Bartlett & Co Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $540K | Hold |
11,100
| – | – | 0.01% | 321 |
|
|
2025
Q1 | $378K | Hold |
11,100
| – | – | 0.01% | 365 |
|
|
2024
Q4 | $437K | Hold |
11,100
| – | – | 0.01% | 342 |
|
|
2024
Q3 | $521K | Hold |
11,100
| – | – | 0.01% | 322 |
|
|
2024
Q2 | $600K | Hold |
11,100
| – | – | 0.01% | 301 |
|
|
2024
Q1 | $757K | Hold |
11,100
| – | – | 0.01% | 292 |
|
|
2023
Q4 | $714K | Hold |
11,100
| – | – | 0.01% | 312 |
|
|
2023
Q3 | $504K | Hold |
11,100
| – | – | 0.01% | 336 |
|
|
2023
Q2 | $623K | Hold |
11,100
| – | – | 0.01% | 313 |
|
|
2023
Q1 | $502K | Hold |
11,100
| – | – | 0.01% | 290 |
|
|
2022
Q4 | $451K | Hold |
11,100
| – | – | 0.01% | 304 |
|
|
2022
Q3 | $725K | Buy |
11,100
+6,000
| +118% | +$392K | 0.02% | 239 |
|
|
2022
Q2 | $310K | Sell |
5,100
-8,500
| -63% | -$517K | 0.01% | 320 |
|
|
2022
Q1 | $854K | Hold |
13,600
| – | – | 0.01% | 238 |
|
|
2021
Q4 | $1.03M | Buy |
+13,600
| New | +$1.03M | 0.02% | 230 |
|